The global Adeno-Associated Virus (AAV) vector-based gene therapy market size reached US$ 5.2 billion in 2023. Looking forward, Reports and Insights expects the market to reach US$ 18.4 billion in 2032, exhibiting a growth rate (CAGR) of 15.1% during 2024-2032.
Read More: https://www.reportsandinsights.com/report/adeno-associated-virus-aav-vector-based-gene-therapy-market